126055-32-1

Basic information

• Product Name: 1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride
• Synonyms: 1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride;-4-methylpiperazine hydrochloride
• CAS NO: 126055-32-1
• Molecular Formula: C₇H₁₅ClN₂*2ClH
• Molecular Weight: 199.12134
• EINECS: -0
• Mol File: 126055-32-1.mol
• Article Data: 4

Chemical Properties

• Melting Point: 279-280 °C (decomp)
• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride(126055-32-1)
• EPA Substance Registry System: 1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride(126055-32-1)

Safety Data

• Hazardous Substances Data: 126055-32-1(Hazardous Substances Data)

Usage

General Description

1-(2-Chloroethyl)-4-Methylpiperazine hydrochloride is a chemical compound that is used in the synthesis of various pharmaceuticals and research chemicals. It is a hydrochloride salt of the organic compound 1-(2-Chloroethyl)-4-Methylpiperazine, which is a piperazine derivative with potential antineoplastic and antimalarial properties. The compound has been studied for its potential applications in the treatment of cancer and malaria. It is also used as a precursor in the synthesis of other pharmaceutical agents and research chemicals. The hydrochloride salt form of 1-(2-Chloroethyl)-4-Methylpiperazine is water-soluble and stable, making it suitable for various laboratory and pharmaceutical applications.

Upstream product

• 109-01-3 1-methyl-piperazine 
• 107-04-0 1-Bromo-2-chloroethane 
• 40676-05-9 2-(4-methyl-piperazino)-ethanol; dihydrochloride 

Downstream Products

• 102321-83-5 1-(2-diphenylamino-ethyl)-4-methyl-piperazine 

Relevant articles and documents

INDENOISOQUINOLINONE DERIVATIVES, MANUFACTURING METHOD AND MEDICAL USE THEREOF

Indenoisoquinolinone derivatives (I), the manufacturing method and the medical use thereof, which belong to pharmaceutical chemistry and organic chemistry field, are disclosed. These compounds can be used for treating several medical symptoms related to postmenopausal syndrome, uterine fibers deterioration and aortic smooth muscle cells proliferation, especially ER-(+) depend breast cancer. Meanwhile, these compounds can also be used for treating glioma and lung cancer, and have inhibiting effect on tumor metastasis effect on tumor metastasis.

Cationic polysaccharides and reagents for their preparation

Cationic polysaccharide derivatives are prepared by reacting a polysaccharide with a polycationic reagent having one polysaccharide reactive group and at least two cationic groups. Suitable reagents include polycationic alkyl, aryl, alkaryl, cycloaliphatic, or heterocyclic amines, some of which are novel compositions. The polycationic polysaccharide derivatives prepared from these reagents are useful in the manufacture of paper.